Changing Epidemiology of Extended-Spectrum β-Lactamases in Argentina: Emergence of CTX-M-15

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 11, 2012, Pages 6003-6005

  Sennati, S ^a   Santella, G ^b   Di Conza, J ^b   Pallecchi, L ^a   Pino, M ^b   Ghiglione, B ^b   Rossolini, G M ^a,c   Radice, M ^b   Gutkind, G ^b  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE CTX M; BETA LACTAMASE CTX M 15; BETA LACTAMASE CTX M 2; BETA LACTAMASE CTX M 8; BETA LACTAMASE CTX M 9; UNCLASSIFIED DRUG;

ARGENTINA; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; KLEBSIELLA PNEUMONIAE; MOLECULAR EPIDEMIOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PREVALENCE; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; ARGENTINA; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENETIC HETEROGENEITY; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE;

EID: 84868031529     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00745-12     Document Type: Article

References (25)

1. Arduino SM, et al. 2002. blaCTX-M-2 is located in an unusual class 1 integron (In35) which includes Orf513. Antimicrob. Agents Chemother. 46:2303-2306.
2. Bado I, et al. 2010. Detection of class 1 and 2 integrons, extended-spectrum β-lactamases and qnr alleles in enterobacterial isolates from the digestive tract of intensive care unit inpatients. Int. J. Antimicrob. Agents 36:453-458.
3. Bartoloni A, et al. 9 February 2012. Relentless increase of resistance to fluoroquinolones and expanded-spectrum cephalosporins in Escherichia coli: 20 years of surveillance in resource-limited settings from Latin America. Clin. Microbiol. Infect. [Epub ahead of print] doi:10.1111/j.1469-0691.2012.03807.x
4. Brigante G, et al. 2005. Evolution of CTX-M-type β-lactamases in isolates of Escherichia coli infecting hospital and community patients. Int. J. Antimicrob. Agents 25:157-162.
5. Bush K. 2010. Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae. Curr. Opin. Microbiol. 13:558-564.
6. Canton R, Coque TM. 2006. The CTX-M β-lactamase pandemic. Curr. Opin. Microbiol. 9:466-475.
7. Clermont O, Bonacorsi S, Bingen E. 2000. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66:4555-4558.
8. Clermont O, et al. 2009. Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J. Antimicrob. Chemother. 64:274-277.
9. Clinical and Laboratory Standards Institute. 2011. Performance standards for antimicrobial disk susceptibility tests. Supplement M02-A10. CLSI, Wayne, PA
10. Clinical and Laboratory Standards Institute. 2011. Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement M100-S21. Clinical and Laboratory Standards Institute, Wayne, PA
11. Dhanji H, et al. 2011. Variation in the genetic environments of blaCTX-M-15 in Escherichia coli from the faeces of travellers returning to the United Kingdom. J. Antimicrob. Chemother. 66:1005-1012.
12. Diancourt L, Passet V, Verhoef J, Grimont PA, Brisse S. 2005. Multi-locus sequence typing of Klebsiella pneumoniae nosocomial isolates. J. Clin. Microbiol. 43:4178-4182.
13. Di Conza J, Ayala JA, Power P, Mollerach M, Gutkind G. 2002. Novel class 1 integron (InS21) carrying blaCTX-M-2 in Salmonella enterica serovar Infantis. Antimicrob. Agents Chemother. 46:2257-2261.
14. Hernandez JR, Martinez-Martinez L, Canton R, Coque TM, Pascual A. 2005. Nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases in Spain. Antimicrob. Agents Chemother. 49:2122-2125.
15. Lavollay M, et al. 2006. Clonal dissemination of a CTX-M-15 β-lactamase-producing Escherichia coli strain in the Paris area, Tunis, and Bangui. Antimicrob. Agents Chemother. 50:2433-2438.
16. Lim KT, Yasin R, Yeo CC, Puthucheary S, Thong KL. 2009. Characterization of multidrug resistant ESBL-producing Escherichia coli isolates from hospitals in Malaysia. J. Biomed. Biotechnol. 2009:165637. doi: 10.1155/2009/165637.
17. Mugnaioli C, et al. 2005. Dissemination of CTX-M-type extended-spectrum β-lactamase genes to unusual hosts. J. Clin. Microbiol. 43:4183-4185.
18. Novais A, et al. 2006. Dissemination and persistence of blaCTX-M-9 are linked to class 1 integrons containing CR1 associated with defective trans-poson derivatives from Tn402 located in early antibiotic resistance plasmids of IncHI2, IncP1-α, and IncFI groups. Antimicrob. Agents Chemother. 50:2741-2750.
19. Pacheco AB, et al. 1997. Random amplification of polymorphic DNA reveals serotype-specific clonal clusters among enterotoxigenic Escherichia coli strains isolated from humans. J. Clin. Microbiol. 35:1521-1525.
20. Pallecchi L, et al. 2007. Rapid dissemination and diversity of CTX-M extended-spectrum β-lactamase genes in commensal Escherichia coli isolates from healthy children from low-resource settings in Latin America. Antimicrob. Agents Chemother. 51:2720-2725.
21. Quinteros M, et al. 2003. Extended-spectrum β-lactamases in Enterobac-teriaceae in Buenos Aires, Argentina, public hospitals. Antimicrob. Agents Chemother. 47:2864-2869.
22. Radice M, Power P, Di Conza J, Gutkind G. 2002. Early dissemination of CTX-M-derived enzymes in South America. Antimicrob. Agents Chemother. 46:602-604.
23. Rossolini GM, D'Andrea MM, Mugnaioli C. 2008. The spread of CTX-M-type extended-spectrum β-lactamases. Clin. Microbiol. Infect. 1:33-41.
24. Woodford N, Turton JF, Livermore DM. 2011. Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol. Rev. 35:736-755.
25. Yagi T, et al. 2005. Practical methods using boronic acid compounds for identification of class C β-lactamase-producing Klebsiella pneumoniae and Escherichia coli. J. Clin. Microbiol. 43:2551-2558.